Umender Sharma

1.3k total citations
28 papers, 960 citations indexed

About

Umender Sharma is a scholar working on Infectious Diseases, Molecular Biology and Ecology. According to data from OpenAlex, Umender Sharma has authored 28 papers receiving a total of 960 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 15 papers in Molecular Biology and 11 papers in Ecology. Recurrent topics in Umender Sharma's work include Bacteriophages and microbial interactions (11 papers), Tuberculosis Research and Epidemiology (9 papers) and Bacterial Genetics and Biotechnology (8 papers). Umender Sharma is often cited by papers focused on Bacteriophages and microbial interactions (11 papers), Tuberculosis Research and Epidemiology (9 papers) and Bacterial Genetics and Biotechnology (8 papers). Umender Sharma collaborates with scholars based in India, United Kingdom and Portugal. Umender Sharma's co-authors include Dipankar Chatterji, Aradhana Vipra, Sreevalli Sharma, Disha Awasthy, Meenakshi Balganesh, Tanjore S. Balganesh, Neela Dinesh, Sandhya K. Nair, Venkita Subbulakshmi and Sowmya Bharath and has published in prestigious journals such as PLoS ONE, Journal of Bacteriology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Umender Sharma

28 papers receiving 928 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Umender Sharma India 19 526 372 272 234 178 28 960
Dana Kocíncová Canada 13 513 1.0× 185 0.5× 198 0.7× 238 1.0× 320 1.8× 19 923
Jeffrey D. Gawronski United States 7 742 1.4× 588 1.6× 452 1.7× 182 0.8× 145 0.8× 9 1.4k
Ján Burian Canada 19 367 0.7× 312 0.8× 253 0.9× 162 0.7× 127 0.7× 38 941
Nagraj Mani United States 18 534 1.0× 588 1.6× 309 1.1× 129 0.6× 151 0.8× 36 1.3k
Martine Fourgeaud France 11 450 0.9× 366 1.0× 403 1.5× 182 0.8× 375 2.1× 16 1.1k
Deborah D. Jaworski United States 8 353 0.7× 263 0.7× 99 0.4× 154 0.7× 151 0.8× 8 763
Sophie Bachellier‐Bassi France 20 777 1.5× 364 1.0× 248 0.9× 200 0.9× 90 0.5× 44 1.2k
Paras Jain United States 22 521 1.0× 710 1.9× 583 2.1× 232 1.0× 186 1.0× 42 1.3k
Daniel Euphrasie France 17 301 0.6× 281 0.8× 327 1.2× 137 0.6× 78 0.4× 25 705
Nathalie T. Reichmann United Kingdom 11 459 0.9× 303 0.8× 74 0.3× 142 0.6× 180 1.0× 11 816

Countries citing papers authored by Umender Sharma

Since Specialization
Citations

This map shows the geographic impact of Umender Sharma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Umender Sharma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Umender Sharma more than expected).

Fields of papers citing papers by Umender Sharma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Umender Sharma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Umender Sharma. The network helps show where Umender Sharma may publish in the future.

Co-authorship network of co-authors of Umender Sharma

This figure shows the co-authorship network connecting the top 25 collaborators of Umender Sharma. A scholar is included among the top collaborators of Umender Sharma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Umender Sharma. Umender Sharma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fraga, Alexandra G., Rita Silva-Gomes, Carine M. Gonçalves, et al.. (2019). Antimicrobial activity of Mycobacteriophage D29 Lysin B during Mycobacterium ulcerans infection. PLoS neglected tropical diseases. 13(8). e0007113–e0007113. 23 indexed citations
2.
Sharma, Umender, et al.. (2018). Phage-derived lysins as potential agents for eradicating biofilms and persisters. Drug Discovery Today. 23(4). 848–856. 80 indexed citations
3.
Nair, Sandhya K., et al.. (2018). Restoration of sensitivity of a diverse set of drug-resistant Staphylococcus clinical strains by bactericidal protein P128. Journal of Medical Microbiology. 67(3). 296–307. 12 indexed citations
4.
Nair, Sandhya K., et al.. (2016). Antibiofilm Activity and Synergistic Inhibition of Staphylococcus aureus Biofilms by Bactericidal Protein P128 in Combination with Antibiotics. Antimicrobial Agents and Chemotherapy. 60(12). 7280–7289. 72 indexed citations
5.
Ravishankar, Sudha, Anisha Ambady, Haripriya Ramu, et al.. (2015). An IPTG Inducible Conditional Expression System for Mycobacteria. PLoS ONE. 10(8). e0134562–e0134562. 8 indexed citations
6.
Ravishankar, Sudha, Anisha Ambady, Disha Awasthy, et al.. (2015). Genetic and chemical validation identifies Mycobacterium tuberculosis topoisomerase I as an attractive anti-tubercular target. Tuberculosis. 95(5). 589–598. 32 indexed citations
7.
Awasthy, Disha, et al.. (2014). Revisiting the essentiality of glutamate racemase in Mycobacterium tuberculosis. Gene. 555(2). 269–276. 13 indexed citations
8.
Awasthy, Disha, et al.. (2014). Roles of the two type II NADH dehydrogenases in the survival of Mycobacterium tuberculosis in vitro. Gene. 550(1). 110–116. 27 indexed citations
9.
Vipra, Aradhana, et al.. (2014). Bacteriophage-derived CHAP domain protein, P128, kills Staphylococcus cells by cleaving interpeptide cross-bridge of peptidoglycan. Microbiology. 160(10). 2157–2169. 21 indexed citations
10.
Ambady, Anisha, et al.. (2012). Evaluation of CoA biosynthesis proteins of Mycobacterium tuberculosis as potential drug targets. Tuberculosis. 92(6). 521–528. 12 indexed citations
11.
Balganesh, Meenakshi, et al.. (2012). Efflux Pumps of Mycobacterium tuberculosis Play a Significant Role in Antituberculosis Activity of Potential Drug Candidates. Antimicrobial Agents and Chemotherapy. 56(5). 2643–2651. 123 indexed citations
12.
Sharma, Umender. (2011). Current possibilities and unresolved issues of drug target validation inMycobacterium tuberculosis. Expert Opinion on Drug Discovery. 6(11). 1171–1186. 18 indexed citations
13.
Sharma, Umender & Dipankar Chatterji. (2010). Transcriptional switching inEscherichia coliduring stress and starvation by modulation of σ70activity. FEMS Microbiology Reviews. 34(5). 646–657. 103 indexed citations
14.
Awasthy, Disha, Anisha Ambady, Jyothi Bhat, et al.. (2010). Essentiality and functional analysis of type I and type III pantothenate kinases of Mycobacterium tuberculosis. Microbiology. 156(9). 2691–2701. 26 indexed citations
15.
Sharma, Umender & Dipankar Chatterji. (2008). Differential Mechanisms of Binding of Anti-Sigma Factors Escherichia coli Rsd and Bacteriophage T4 AsiA to E. coli RNA Polymerase Lead to Diverse Physiological Consequences. Journal of Bacteriology. 190(10). 3434–3443. 24 indexed citations
16.
Bhat, Jyothi, Suresh Solapure, Dhiman Sarkar, et al.. (2006). High-Throughput Screening of RNA Polymerase Inhibitors Using a Fluorescent UTP Analog. SLAS DISCOVERY. 11(8). 968–976. 21 indexed citations
17.
Sharma, Umender & Dipankar Chatterji. (2006). Both regions 4.1 and 4.2 of E. coli σ70 are together required for binding to bacteriophage T4 AsiA in vivo. Gene. 376(1). 133–143. 6 indexed citations
19.
Sharma, Umender, et al.. (1993). Deletion analysis of the essentiality of penicillin-binding proteins 1A, 2B and 2X ofStreptococcus pneumoniae. FEMS Microbiology Letters. 106(2). 171–175. 65 indexed citations
20.
Sharma, Umender, et al.. (1991). Identification of carbohydrate structures as receptors for localised adherent enteropathogenic Escherichia coli. Microbial Pathogenesis. 11(4). 259–268. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026